Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway

Journal of Pineal Research

Volumn 32, Issue 4, 2002, Pages 262-269

  Chen, Shur Tzu ^a   Chuang, Jih Ing ^a   Hong, Mei Huei ^a   Li, Eric I Chian ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

1 methyl 4 phenyl pyridinium ion; Glutathione; L. buthionine sulfoximine; Melatonin; Nigrostriatal neurodegeneration; Oxidative stress

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BUTHIONINE SULFOXIMINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; MELATONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; MALE; NERVE DEGENERATION; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CORPUS STRIATUM; DOPAMINE; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MELATONIN; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0036255661     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2002.01871.x     Document Type: Article

References (49)

1. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
2. Neurochemical and behavioral effects of systemic and intranigral administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat, guinea pig and monkey
3. Oxygen free radicals and Parkinson's disease
4. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia
5. Effect of MPTP and 1-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain
6. +) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat
7. Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse
8. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: Potential implications to Parkinson's disease
9. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
10. Glutathione-related enzymes in brain in Parkinson's disease
11. Glutathione: New candidate neuropeptide in the central nervous system
12. Glutathione, ascorbate, and cellular protection
13. + toxicity in nigral dopaminergic neurons
14. The role of glutathione in dopaminergic neuronal survival
15. The melatonin rhythm: Both a clock and a calendar
16. Melatonin: A potent, endogenous hydroxyl radical scavenger
17. Melatonin: A peroxyl radical scavenger more effective than vitamin E
18. Actions of melatonin in the reduction of oxidative stress
19. Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues
20. Acutely administered melatonin reduces oxidative damage in lung and brain induced by hyperbaric oxygen
21. The antioxidant melatonin prevents kainate-induced neuronal degenerating death in the rat striatum
22. Suppression of hydroxyl radical formation by MAO inhibitors: A novel possible neuroprotective mechanism in dopaminergic neurotoxicity
23. The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications
24. + produces progressive neuronal degeneration which is mediated by oxidative stress
25. Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration
26. Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats
27. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats
28. Tyrosine hydroxylase activity: Regional and subcellular distribution in brain
29. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice
30. +-induced cell death in a dopaminergic neuronal cell line: Role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins
31. +-induced apoptosis in human SH-SY5Y neuroblastoma cells
32. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glia cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
33. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
34. Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice
35. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways
36. Biologic and pharmacologic regulation of mammalian glutathione synthesis
37. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: Applications in research and therapy
38. Different effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells
39. Metals and free radicals in neurodegeneration
40. +) neurotoxicity in rats
41. Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats
42. Melatonin is protective against MPTP-induced striatal and hippocampal lesion
43. Protective effect of melatonin against the 1-Methyl-4-phenyl-pyridinium-induced inhibition of complex I of the mitochondrial respiratory chain
44. Melatonin induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo
45. Melatonin, mitochondria, and cellular bioenergetics
46. Enhanced glial cell line-derived neruotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments
47. Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment
48. + in the rat